IMPORT SUBSTITUTION PRESERVING DEVELOPMENT GAP
Processes of globalization became an integral part of world economy. In this regard investigational and production units and headquarters of a modern pharmaceutical manufacturer can be located not only in different countries but on different continents. Therefore the terms «foreign» and «domestic» manufacturers are becoming less actual, and the term «import substitution» should be considered as not correct one. Russian pharmaceutical market should include medicines not in terms of place of their production but in terms of efficacy, safety, quality and correspondence of manufacturers facilities to internationally harmonized GMP rules.